Skip to content

Author

Jing-Xin Li

We have 3 of 16 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Clinical trial Open access Sep 2026

Dissociation between humoral and multi-omic immune responses to inactivated COVID-19 vaccination in patients with pulmonary tuberculosis

Introduction Patients with pulmonary tuberculosis (PTB) may experience persistent immune dysregulation during anti-tuberculosis treatment, yet vaccine evaluation in this population has largely relied on humoral endpoints. Whether preserved antibody responses reflect coordinated systems-level immune activation after ina...

Zhi-Jie Jiang, Peng-Fei Jin, Xiao-Rui Nie et al. · 0 citations
Open access Aug 2026

Serum Escape Landscape of SARS-CoV-2 Omicron JN.1 and XEC RBD Under COVID-19 Vaccine Breakthrough Immunity in China

The findings suggest that SARS-CoV-2 antigenic evolution follows the pattern of multiple pathways within a constrained space, providing new insights into the adaptive mechanisms of Omicron-derived variants under hybrid immune pressure.

Cheng-Wei Shao, Jian-Guang Fu, Fei Deng et al. · 0 citations
Open access Jul 2026

Systemic immune profiling of heterologous versus homologous boosting of COVID-19 vaccination.

Heterologous boosting with Ad5-nCoV elicited more mature B cells with higher affinity and activated more abundant immune-related pathways compared to the homologous boosting with CoronaVac, which gives insights for elaborating the systemic immune landscape of heterologous-boosting COVID-19 immunization by the novel sin...

Xu Han, Hudachuan Jiang, Hui Zheng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.